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Abatract 
Incubation of rat skeletal muscle mitochondria with the nitric oxide generator, S-nitrosoglutathione (GSNO) reversibly inhibited oxygen utilisation 
with all substrates tested. The visible absorption spectra of the inhibited mitochondria showed that cytochromes c + c,, b and a + a3 were reduced, 
indicating a block at the distal end of the respiratory chain. Analysis of the respiratory chain enzyme activities in the presence of GSNO localised 
the site of inhibition to cytochrome c oxidase alone. These results indicate that nitric oxide is capable of rapidly and reversibly inhibiting the 
mitochondrial respiratory chain and may be implicated in the cytotoxic effects of nitric oxide in the CNS and other tissues. 
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1. IntroductioIl 
The nitric oxide (No’) radical has been shown to be 
produced by cytotoxic activated macrophages (CAM) 
during metabolism of L-arginine to NO-JN03 [l]. The 
NO’ produced is capable of inhibiting a number of mi- 
crobial and tumour cell targets [2,3]. CAM have been 
shown to induce intracellular iron loss [4-61, and inhibi- 
tion of DNA synthesis [7,8], aconitase [5] and complexes 
I and II of the mitochondrial electron transport chain 
[5,6-lo]. All of these enzymes have catalytically active 
non-haem iron, coordinated to sulphur which could be 
the site of interaction of NO’ with these enzymes. Fur- 
thermore, the inhibitory effect of NO’ is believed to be 
caused by its degradation of iron-sulphur centres, result- 
ing in the release of Fe ions and Fe-nitrosyl complexes 
[11,12]. Such cytotoxic effects of NO’ may not be re- 
stricted to activated macrophages, for example, Ca2’- 
dependent NO’ release has been described in cerebellar 
neurones in response to glutamate [13]. 
The dual observations of gliosis [14] and a deficiency 
of mitochondrial complex I activity in the substantia 
nigra in Parkinson’s disease (PD) [ 15,161, raises the pos- 
sibility that NO’ released from activated microglia may 
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be involved in neuronal loss in PD via inhibition of 
complex I activity. To gain a better understanding of the 
effects of NO’ on the respiratory chain and to help deter- 
mine its possible role in the pathogenesis of PD, we 
exposed isolated intact or permeabilised mitochondria to 
an NO’ donor and analysed the effect of this treatment 
on oxygen utilisation, the visible absorption spectrum of 
the cytochromes and on the individual respiratory chain 
enzyme activities. 
2. Materials and methods 
2.1. Chemicals 
Chemicals were obtained from Merck (Poole, UK) and Sigma Chem- 
icals. GSNO was synthesised at Wellcome Research Laboratories as 
described [17]. 
2.2. Respiration measurements 
Rat gastrocnemius muscle mitochondria were prepared as described 
[18]. Mitochondrial oxygen utilisation was measured polarographically 
at 25°C essentially as described [19] but in a fmal volume of 2OOpl using 
a Clark type micro oxygen electrode (Model 5357, YSI inc. Yellow 
Springs, OH). Intact mitochondria (respiratory control ratio >4 with 
glutamate as substrate) were used for all polarographic experiments. 
Mitochondria that had been rendered permeable by freeze-thawing 
(three cycles) were used for spectrophotometric measurement of en- 
zyme activities (see below). 
2.3. Effect of GSNO 
Variable amounts of GSNO (t&500 uM) were added to incubation 
mixtures containing: respirationmedium (see [19] for details), BSA (0.5 
mg/ml), Dl’T (50 @I) and mitochondria (0.7-1.0 mg.protein.ml-‘) 
1 min prior to the addition of the substrate and sufficient ADP (600 
nmol) to enable state III respiration to continue until anoxia, which 
typically occurred 3-4 min after addition of ADP. Where indicated, the 
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incubation time before addition of substrate and ADP was varied in 
order to examine the effect of me-incubation of GSNO and DTT with 
mitochondria. The reversibiliiy of the NW-dependent inhibition of 
mitochondria was assessed after polarographic analysis of the mito- 
chondtia with glutamate, malate and ADP. The incubation mixture was 
removed, centrifuged at approximately 7000 x g at 20°C on a bench top 
centrifuge for 2 mitt and the supernatant aspirated. Samples were care- 
fully resuspended in respiration medium and oxygen consumption 
again monitored in the presence of glutamate, malate and ADP 
2.4. Preparation of oxyhaemoglobin (HbO,) and estimation of the rate 
of NCY production 
Oxyhaemoglobin was prepared as described previously [20]. The rate 
of NO’ production was determined by the spectrophotometric measure- 
ment of the production of methaemoglobin from HbOr at 25°C [21]. 
2.5. Viiible absorption spectra of mitochondrial cytochromes 
The spectrum of fresh or freeze-thawed mitochondria (1 mg/ml) was 
determined (500 nm to 630 mn) in the following buffer: 225 mM man- 
nitol, 75 mM sucrose, 5 mM phosphate-Tris, TO mM MOPS and 100 
PM potassium EDTA, pH 7.4, using a Hitachi U-3210 spectrophotom- 
eter. A sample of mitochondria from the same preparation was used 
as an optical reference. The following additions were made sequentially 
to the sample cuvette: D’lT (50 pM), GSNO (190 PM) and succinate 
(25 PM) or NADH (150 PM in freeze-thawed mitochondria) and the 
spectrum taken. 
2.6. Spectrophotometric measurement of enzyme activities 
NADH CoQ, reductase (complex I), succinate-cytochrome c reduc- 
tase (complex II-III) and cytochrome c oxidase (complex IV) were 
measured by published methods [22-241. Protein was estimated using 
fatty acid free BSA as a standard [25]. 
3. Results 
3.1. Effects of NC on intact mitochondria 
The addition of GSNO (from O-500 PM) with DTT 
(50 ,uM) to mitochondria caused a concentration de- 
pendent inhibition of the total oxygen utilisation by the 
mitochondria, although only at the highest concentra- 
tions of GSNO (190-500 PM) were the initial state III 
respiration rates also decreased (Fig. 1). This inhibition 
was seen with all substrates tested: glutamate/malate; 
succinate and ascorbate/TMPD (Fig. 2A). Increasing the 
time between exposure of mitochondria to No’ and the 
addition of substrate, decreased the apparent inhibition 
of the respiratory chain, suggesting that the inhibitory 
effect was either reversible or dependent upon electron 
transfer within the respiratory chain (Fig. 2B). For ex- 
ample, after 30 min of pre-incubation with 190 PM 
GSNO and 50 PM DTT, approximately 66% of available 
oxygen was consumed by mitochondria before complete 
inhibition compared to only 12% when the pre-incuba- 
tion was for 1 min. 
In the presence of DTT the rates of NO’ production 
from GSNO ranged from 0 to 7.6 mnol*min-’ .ml-’ for 
concentrations of GSNO between O-500 PM (Fig. 2C) 
and were comparable to the rates of generation of NO 
from activated neuronal cells and macrophages [21]. In 
the absence of DTT, rates were approximately fourfold 
less. With 190 ,uM GSNO (+50 ,uM DTT) the rate of 









Fig. 1. Representative traces from the oxygen electrode showing the 
effect of increasing concentrations of GSNO on oxygen consumption 
by isolated rat skeletal muscle mitochondria in the presence of: GSNO 
and 50 pM DlT and the addition of glutamate, malate and ADP after 
lmitl. 
reagents was negligible (data not shown). The inhibition 
of mitochondrial oxygen utilisation by GSNO was de- 
pendent upon the presence of DTT (Table l), consistent 
with the transnitrosation of No’ from GSNO to DTT 
and the subsequent decomposition of the less stable ni- 
trosothiol. However, the addition of 50 ,uM DTT alone 
to respiring mitochondria had no effect on rates of oxy- 
gen utilisation (Table 1). To help to exclude the possibil- 
ity that products from the decomposition of 
GSNO + DTT other than NO’ were having an inhib- 
itory action on mitochondria, GSNO and DTT were 
preincubated for 150 min at room temperature, to allow 
the complete decomposition of the GSNO and the oxida- 
tion of the NO’ generated. Subsequent addition to mito- 
chondria had no inhibitory effect on mitochondrial oxy- 
Table 1 
Effect of DTT, HbOz, GSSG, decomposition of GSNO and washing 
on mitochondrial oxygen utilisation 
Addition Control + GSNO 
DTT 
After Washing 
HbO, f Dl-f 
Decomposed GSNO 
GSSG 
85 f 3 85 + 7 
81 f4 21 f4 
89 f 2 83 f 6 
74 * 4 81 f6 
9of2 ND 
79 f 10 ND 
The effect of various additions upon oxygen utilisation by rat skeletal 
muscle mitochondria (ng atom 4 min after the addition of glutamate, 
malate and ADP, mean f S.D., n = 3). The additions were GSNO (190 
PM), DTT (50pM), HbOz (24pM), decomposed GSNO (190pM). ND 
= not determined. 
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gen utilisation (see Table 1). The addition of oxidised 
glutathione (GSSG), a product of the decomposition of 
GSNO, to mitochondria had no significant effect on ox- 
ygen use (Table 1). The presence of oxyhaemoglobin 
prevented the inhibition of mitochondrial oxygen utilisa- 
tion due to GSNO and DTT (Table l), providing further 
evidence that No’ was the inhibitory agent. 
Washing the mitochondria after inhibition with 
GSNO/DlT resulted in restoration of oxygen utilisation 
with all substrates suggesting the inhibitory effect of NO 
was fully reversible (Table 1). 
The visible absorption spectra of mitochondria in the 
region of 500-630 mu showed characteristic absorption 
maxima at 550 nm (cytochromes c + cJ, 560 nm (cyto- 
chrome b) and 601 nm (cytochromes a + a3 following 
the addition of GSNO, DTT and succinate. These peaks 
were not observed, however, if any one of the three addi- 
tions were omitted (data not shown). Similar results were 
obtained using freeze-thawed mitochondria, except that 
DTT was not required. 
3.2. The effects of No’ on freeze-thawed mitochondria 
The effect of NO’ upon the individual respiratory 
chain complexes was determined spectrophotometri- 
tally, using freeze-thawed mitochondria. GSNO up to 
a concentration of 500 ,uM (+DTT 50 JLM) in the as- 
say itself failed to have any significant effect on NADH 
CoQ, reductase or succinate cytochrome c reductase ac- 
tivities (complex I and complexes II-III respectively). 
The activity of cytochrome c oxidase, however, was sig- 
nificantly affected with 50% inhibition occurring at 10 
PM GSNO in the presence of 50 PM DTT, compared to 
45 PM GSNO in the absence of DTT (Fig 3). The possi- 
bility that GSNO or NO’ was reacting with the cyto- 
chrome c in the assay medium and rendering it resistant 
to oxidation was discounted as addition of ferricyanide 
caused virtually complete oxidation of cytochrome c 
(data not shown). 
4. Discussion 
GSNO has been shown to decompose principally to 
GSSG and NO’ [27] a process accelerated in the presence 
of thiolate anions such as D’TT. The addition of GSNO 
to isolated mitochondria resulted in the inhibition of 
oxygen utilisation when using glutamate, succinate or 
ascorbate/TMPD as substrate, consistent with inhibition 
of complex IV. Several observations suggest NO’ as the 
cause of this inhibition. Firstly, GSNO alone has no 
effect on electron transport and in intact mitochondria, 
inhibition required the presence of DTT. Secondly, respi- 
ratory chain function was protected by the addition of 
HbOz (which has a high affiity for NO’), and thirdly, 
the addition of decomposed GSNO and DTT failed to 
inhibit oxygen utilisation by the mitochondria, presuma- 
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Fig. 2. (A) The effect of GSNO and DTT on skeletal muscle mitochon- 
drial respiration using: glutamate/malate (o), succinate (v) and ascor- 
bateiTMPD (0) as substrate. Results are expressed as the amount of 
oxygen consumed 4 min after the addition of substrate and ADP (the 
time taken for the zero GSNO incubation to use >95% of the available 
oxygen in the incubation mixture). (B) The effect of incubation of 
GSNO (190 PM) and DTI (50 PM) with mitochondria prior to the 
addition of substrates and ADP. Substrates (glutamatelmalate) and 
ADP were added after various times and the oxygen consumption 
calculated. (C) The rate of NO’ generation by GSNO. Incubations were 
set up in respiration medium containing various concentrations of 
GSNO (0) or GSNO with DTT (0). 
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Fig. 3. The effect of varying GSNO concentration on the specific activ- 
ities of respiratory chain complexes in freeze-thawed mitochondria; 
o, cytochrome c oxidase; l , cytochrome c oxidase in the presence of 50 
,uM DTT, A, NADH-CoQ, reductase in the presence of 50 ,uM DTT, 
V, succinate cytochrome c reductase in the presence of 50 PM DTT. 
bly because most of the NO’ release from GSNO took 
place within the first 15 min and was subsequently oxi- 
dised to nitrate and nitrite. Consequently, it can be con- 
cluded that neither GSNO per se nor its stable oxidation 
products (GSSG, nitrate and nitrite) had any effect upon 
mitochondrial respiratory chain function at the concen- 
trations used. 
The reduction of all the cytochromes in the presence 
of GSNO indicated that the respiratory chain was inhib- 
ited at cytochrome a3 which, together with CU~+~, forms 
part of the oxygen binding site of cytochrome c oxidase. 
The addition of both succinate and NADH (in freeze- 
thawed mitochondria) caused reduction of the cyto- 
chromes in the presence of GSNO and oxygen suggesting 
that complexes I, II and III were not significantly inhib- 
ited by GSNO or NO’. The localisation of the defect to 
complex IV and normal function of complexes I to III 
is further supported by measurement of the activity of 
segments of the respiratory chain (Fig. 3). Although inhi- 
bition of cytochrome c oxidase by GSNO in freeze- 
thawed mitochondria was not totally dependent upon 
the presence of DTT, the free thiols released from within 
the mitochondria by freeze-thawing may have been suffi- 
cient to catalyse the release of NO’ from GSNO. These 
results are consistent with those of the cytochrome spec- 
tra, in which freeze-thawed mitochondria only required 
substrate and GSNO for the appearance of the reduced 
cytochrome peaks, whereas intact mitochondria also re- 
quired DTT. 
The kinetics of the inhibition of cytochrome c oxidase 
by No’ described here are such that complete inhibition 
can be seen within 4 min of adding substrates and ADP 
to mitochondria. The effect of incubation of the resting 
enzyme with NO’ on its ESR (electron spin resonance) 
spectrum has been reported previously [28] and suggest 
that NO’ reacts with the Cu”,’ centre in a reversible fash- 
ion. Binding of NO’ to the reduced form of cytochrome 
c oxidase is believed to occur at the haem iron of cyto- 
chrome a3, NO’ being the sixth ligand. Reduced cyto- 
chrome c oxidase has been shown to react rapidly with 
NO’ with a k value of 4 x lo7 M-l. s-’ but would proba- 
bly not be able to compete for oxygen at this site [29]. 
From the present data, it is not clear which redox form 
of cytochrome c oxidase is binding NO’, however elec- 
tron transfer appears to be necessary for inhibition. 
There have been other reports in the literature on the 
effect of NO’ or activated macrophages on mitochon- 
drial function. Polarographic analysis of digitonin per- 
meabilised L1210 cells after incubation with authentic 
NO’ solutions for 5 min [30] found that complexes I and 
II were inhibited, oxygen utilisation being reduced to 
16.4 and 44.1% of control levels respectively. An earlier 
study [lo] using cytotoxic macrophages to injure L1210 
cells found that complexes I, II and to a lesser extent 
complex IV, were inhibited (92%, 81% and 15%, respec- 
tively) as determined polarographically with digitonin 
treated cells. The difference in enzyme inhibition seen in 
these two studies and the present work may, in part, be 
explained by the different methodologies, in particular 
the use of whole cells rather than isolated mitochondrial 
fractions. In the two studies mentioned above, the use of 
digitonin prior to the cells being assayed may allow NO 
to dissociate from cytochrome c oxidase, and therefore 
inhibition of complex IV would not be expected on the 
basis of the present report. The inhibition of complexes 
I and II may be more permanent, possibly as a result of 
more prolonged exposure to No’. We suggest that the 
initial (acute) effect of NO’ exposure on the respiratory 
chain is the inhibition of mitochondrial respiration at 
cytochrome c oxidase. Longer term effects may indeed 
involve the inhibition of complexes I and II reported 
previously, perhaps leading to cytotoxicity . This inhibi- 
tion could be due to reaction with NO’ itself or with 
peroxynitrite, a product of the reaction between NO’ and 
superoxide [31]. Superoxide production is a by-product 
of mitochondrial respiratory electron transfer and has 
been shown to increase in the presence of mitochondrial 
inhibitors such as rotenone, antimycin A and cyanide 
[32]. The site of this additional superoxide formation is 
believed to be within complexes I and III. NO’, as an 
inhibitor of cytochrome oxidase, may contribute to the 
inhibition of complexes I and II by further promoting 
free radical or peroxynititrite formation, or both. 
Whether such mechanisms are relevant to Parkinson’s 
disease and other neurodegenerative disorders obviously 
requires further investigation, but it is of interest to note 
that inhibition of cytochrome oxidase is required for the 
irreversible loss of complex I activity in a chemical model 
of Parkinson’s disease [33]. 
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